CLINICAL_TRIALS
trial_result
· 2021-09-09
Clinical Trial Update: Panitumumab Skin Toxicity Prevention Trial [Phase 2]
Summary
Phase 2 clinical trial update for Panitumumab focusing on prevention of skin toxicity in metastatic colorectal cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ospedale San Carlo Borromeo | Conditions: Colorectal Cancer Metastatic, Skin Toxicity | Phase 2 | Status: UNKNOWN